Explore

3D Printing-Inspired Technology Advances Personalized Medicine for Tailored Dosing

3D Printing-Inspired Technology Advances Personalized Medicine for Tailored Dosing

Technology inspired by 3D printing is being implemented in hospitals and specialized pharmacies to create personalized medicines. This approach allows for the production of medications with doses specifically tailored to individual patients, addressing a critical need for groups such as children and older patients who often require dosages not available in standard commercial products. The system utilizes a 3D printing-inspired manufacturing process to dispense precise amounts of a gel-like formulation, enabling pharmacists to produce patient-specific treatments while maintaining consistent quality. Research conducted by Mahsa Bahman at Åbo Akademi University investigated the efficacy of this technology in manufacturing a wide range of personalized medicines, evaluating factors like dose accuracy, product quality, stability, and consistency, and its performance within a hospital pharmacy environment. This innovation aims to improve dosing accuracy and broaden access to customized treatments.

Study Identifies Beta-Synuclein as Early Blood Biomarker for Alzheimer's in Down Syndrome Patients

Study Identifies Beta-Synuclein as Early Blood Biomarker for Alzheimer's in Down Syndrome Patients

A new study, published in Alzheimer's & Dementia, has identified beta-synuclein as a promising early blood-based biomarker for Alzheimer's disease in individuals with Down syndrome. Researchers from Sant Pau Research Institute (IR Sant Pau), in collaboration with Martin Luther University and the German Center for Neurodegenerative Diseases, found that beta-synuclein levels begin to rise in people with Down syndrome from their third decade of life, approximately 21 years before the average age of prodromal Alzheimer's diagnosis in the studied cohort. Beta-synuclein, a protein primarily located at presynaptic terminals, provides insights into synaptic dysfunction and degeneration, which are considered early events in Alzheimer's. The study analyzed 131 individuals, including 88 adults with Down syndrome at various disease stages and 43 cognitively healthy controls. Results showed beta-synuclein levels were 1.83 times higher in asymptomatic Down syndrome individuals compared to controls, increasing with disea...

Precision Medicine Seeks Shipping Associate in Boca Raton, Florida to Enhance Personalized Healthcare Solutions

Precision Medicine Seeks Shipping Associate in Boca Raton, Florida to Enhance Personalized Healthcare Solutions

Precision Medicine, a company focused on revolutionizing healthcare through accessible, personalized, and efficient solutions, is actively seeking a Shipping Associate for its Boca Raton, FL location. This full-time, on-site position within the Compounding Pharmacy department offers a salary of $17.00–$19.00 per hour, with a Monday to Friday schedule from 9:00 AM to 5:00 PM. The Shipping Associate will report directly to the Site Leader and be responsible for various duties including packing, filling, and shipping orders accurately and efficiently. Key responsibilities also involve utilizing technology for tracking and shipping packages, maintaining a clean work area, performing inventory counts, and being flexible to support different pharmacy needs. The role emphasizes supporting safe and reliable patient care by ensuring products are packed, documented, and shipped correctly and on time. Candidates are expected to have strong attention to detail, the ability to lift heavy objects, and experience in a fa...

Memorial Sloan Kettering Researchers Challenge Age-Based Genetic Testing for Cancer, Citing 72% Miss Rate of Inherited Variants

Memorial Sloan Kettering Researchers Challenge Age-Based Genetic Testing for Cancer, Citing 72% Miss Rate of Inherited Variants

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published findings in Cancer Discovery indicating that age-based criteria for germline genetic testing in cancer patients miss 72% of individuals with pathogenic inherited cancer variants. The study analyzed nearly 40,000 adults across 32 types of solid tumors. While early-onset cancers showed an enrichment of pathogenic germline variants, inherited variants were also found in patients diagnosed at average and older ages. Due to the higher prevalence of cancer later in life, restricting testing to younger patients leads to a significant number of mutation carriers being overlooked. Dr. Zsofia Stadler, a medical oncologist and clinical geneticist at MSK and a principal investigator of the study, emphasized that using age cutoffs as a criterion for genetic testing results in missing the vast majority of patients with an inherited cancer predisposition syndrome. The research suggests a simpler approach: offering germline testing to all adults di...

Precision Psychiatry Aims to Revolutionize Mental Health Treatment with Individualized Approaches

Precision Psychiatry Aims to Revolutionize Mental Health Treatment with Individualized Approaches

Precision psychiatry is emerging as a science-based approach to mental health care, aiming to tailor treatments to each patient's individual genetic, neurobiological, psychological, and environmental profile. This model seeks to move beyond the current trial-and-error methods often used in psychiatry, which rely on broad diagnostic categories and symptom clusters. Psychiatric disorders are highly heterogeneous, meaning patients with the same diagnosis can have vastly different underlying causes and responses to treatment. Precision psychiatry integrates advances in genomics, neuroimaging, digital phenotyping, and cognitive assessment to provide more nuanced understanding and targeted interventions. While other medical specialties have long utilized validated biomarkers, psychiatry has lagged due to the complex interplay of genetic, environmental, and psychosocial factors, and the difficulty in directly sampling the brain. However, emerging technologies like pharmacogenetic testing and digital cognitive ass...

Research Links Stable Circadian Rhythms to Improved Blood Glucose Control in Type 2 Diabetes Patients

Research Links Stable Circadian Rhythms to Improved Blood Glucose Control in Type 2 Diabetes Patients

A research team, including Dr. Lee Da young and Dr. Nan Hee Kim from Ansan Hospital, has found a significant correlation between stable circadian rhythms and better blood glucose management in individuals with type 2 diabetes. The study, published in the journal Metabolism, involved 122 patients with type 2 diabetes receiving insulin treatment at Ansan Hospital between 2021 and 2024. Participants wore continuous glucose monitors (CGM) and wearable activity monitors for 10 days to collect data on blood glucose fluctuations, sleep patterns, physical activity levels, and heart rates. The findings revealed that 46.3% of patients with the most stable circadian rhythms achieved their blood glucose management goals, a rate approximately 2.3 times higher than the 20.0% observed in patients with the least stable rhythms. This association remained significant even after adjusting for factors such as age, BMI, and HbA1c. The research also indicated that afternoon activity had the strongest correlation with blood gluc...

MSK Study Challenges Age-Based Genetic Testing for Inherited Cancer Variants, Advocates Broader Screening

MSK Study Challenges Age-Based Genetic Testing for Inherited Cancer Variants, Advocates Broader Screening

A new study conducted by researchers at Memorial Sloan Kettering Cancer Center (MSK) indicates that relying on age as a primary criterion for germline genetic testing in cancer patients misses a significant majority of individuals with inherited cancer variants. The analysis, which involved nearly 40,000 adults across 32 types of solid tumors, revealed that age-based testing would fail to identify 72% of patients carrying pathogenic germline variants. While early-onset cancers showed an enrichment of these variants, inherited mutations were also prevalent in patients diagnosed at average and older ages. This challenges the traditional assumption that inherited cancer predisposition is mainly a concern for younger patients. The study suggests that the current complex guidelines for germline testing, which often depend on combinations of age, family history, ancestry, and tumor characteristics, may inadvertently limit access to crucial genetic information. Dr. Zsofia Stadler, a medical oncologist and clinica...

National MS Society Launches $1 Billion 'Campaign to End MS' to Accelerate Research and Patient Support

National MS Society Launches $1 Billion 'Campaign to End MS' to Accelerate Research and Patient Support

The National MS Society has initiated a $1 billion fundraising effort, dubbed the 'Campaign to End MS,' aimed at accelerating research breakthroughs, expanding access to patient care, and providing support for individuals and families affected by multiple sclerosis (MS). This five-year campaign, launched on October 1st, is described as the most ambitious in the organization's 80-year history. At its launch, a gala in New York City raised over $12 million for MS research. The campaign seeks to help approximately 1 million people in the U.S. living with MS receive earlier diagnoses, access timely treatment, and find necessary support. MS is a neurodegenerative disease where the immune system attacks the brain and spinal cord, leading to symptoms like fatigue, movement issues, vision problems, and cognitive difficulties, for which there is currently no cure.

Compounding Pharmacies Offer Custom Tretinoin Formulations Beyond Standard Commercial Strengths

Compounding Pharmacies Offer Custom Tretinoin Formulations Beyond Standard Commercial Strengths

Compounding Pharmacies Offer Custom Tretinoin Formulations Beyond Standard Commercial Strengths

Northwestern Study Reveals Long-Term Opioid Use Ineffective for Chronic Back Pain, Identifies New Molecular Markers

Northwestern Study Reveals Long-Term Opioid Use Ineffective for Chronic Back Pain, Identifies New Molecular Markers

A new study from Northwestern University indicates that long-term opioid use does not significantly improve pain or functioning in individuals suffering from chronic back pain. The research compared 70 long-term opioid users with 70 similar patients who were not taking opioids. Both groups reported nearly identical pain levels, averaging 5.4 on a 10-point scale, suggesting that years of opioid use did not lead to better pain management. While the opioid group showed slightly worse outcomes in physical function and mental health, their brain anatomy remained largely intact, dispelling fears that long-term opioid ingestion severely damages the brain. However, significant differences were observed in spontaneous brain activity, particularly in the mesocorticolimbic network (involved in reward and motivation) and the prefrontal cortex (supporting decision-making). The study, published in the journal Brain, also identified new molecular markers, including those related to serotonin receptors, which could pave t...

MMRF-Led Study Uncovers Unique Immune Features in Multiple Myeloma Patients of African Ancestry

MMRF-Led Study Uncovers Unique Immune Features in Multiple Myeloma Patients of African Ancestry

A new study led by the Multiple Myeloma Research Foundation (MMRF), in collaboration with the Mayo Clinic and Emory University, has identified previously unknown immune features in multiple myeloma patients with African ancestry. Published in the journal Blood, this research utilized genomic data to analyze patients with varying levels of African genetic similarity, moving beyond self-reported race. The study found that patients with high African genetic similarity exhibited a distinct bone marrow immune microenvironment characterized by less inflammation and a higher presence of cancer-fighting immune cells. A significant discovery was the prevalence of cytotoxic CD4+ T cells in these patients, which, unlike their typical 'helper cell' role, displayed direct cancer-killing capabilities by expressing genes associated with cytotoxicity. This finding suggests a unique biological characteristic within this patient population. The research leveraged two critical MMRF datasets: the MMRF Immune Atlas, providing ...

University of Missouri Advances Molecular Imaging for Personalized Medicine

University of Missouri Advances Molecular Imaging for Personalized Medicine

The University of Missouri's Molecular Imaging and Theranostics Center is at the forefront of advancing molecular imaging, a critical field intersecting molecular biology and medical imaging. This discipline is fundamental to personalized medicine and precision health, enabling non-invasive visualization of the molecular basis of diseases and their responses to treatment. Over the past few decades, molecular imaging has transitioned into clinical practice with FDA approvals for agents like fluorine-18-labeled fluorodeoxyglucose (FDG) for PET imaging in various cancers and Alzheimer’s disease. Additional PET agents have also been approved for neurological diseases and other cancers. Beyond PET scans, molecular imaging is utilized in SPECT scans and MRIs. While significant progress has been made in clinical applications, researchers emphasize that current achievements are just the beginning. The future of molecular imaging holds immense potential to enhance drug development, facilitate earlier disease diagno...